Medtronic (MDT) Free Cash Flow (2014 - 2026)

Medtronic has disclosed Free Cash Flow across 13 years of filings, most recently posting $2.3 billion for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $2.3 billion, up 9.73% year-over-year; the trailing twelve-month figure through Jan 2026 was $5.4 billion (down 1.04% YoY), and the FY2025 annual result was $5.2 billion, changed 0.29% from the prior year.
• Free Cash Flow came in at $2.3 billion for Q1 2026 at Medtronic, up from $457.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $2.4 billion in Q2 2024 to a low of $200.0 million in Q4 2023.
• The 5-year median for Free Cash Flow is $1.2 billion (2023), against an average of $1.3 billion.
• Across the five-year window, Free Cash Flow tumbled 66.61% in 2023 and soared 177.0% in 2024, its largest moves.
• Medtronic's Free Cash Flow stood at $599.0 million in 2022, then sank by 66.61% to $200.0 million in 2023, then jumped by 177.0% to $554.0 million in 2024, then declined by 17.51% to $457.0 million in 2025, then surged by 403.28% to $2.3 billion in 2026.
• The last three Free Cash Flow figures came in at $2.3 billion (Q1 2026), $457.0 million (Q4 2025), and $584.0 million (Q3 2025), per Business Quant data.